tailieunhanh - Báo cáo y học: " Pregnancy and delivery while receiving vagus nerve stimulation for the treatment of major depression: a case report"

Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học General Psychiatry cung cấp cho các bạn kiến thức về ngành y đề tài: Pregnancy and delivery while receiving vagus nerve stimulation for the treatment of major depression: a case report. | Annals of General Psychiatry BioMed Central Case report Open Access Pregnancy and delivery while receiving vagus nerve stimulation for the treatment of major depression a case report Mustafa M Husain Diane Stegman and Kenneth Trevino Address University of Texas Southwestern Medical Center at Dallas 5323 Harry Hines Blvd Dallas Texas 75390-8898 USA Email Mustafa M Husain - Diane Stegman - Kenneth Trevino - Corresponding author Published 16 September 2005 Received 25 July 2005 . AAAI- ZIZ J_. IA I Irtz ITZZ rti-oxz A IZ Accepted 16 September 2005 Annals of General Psychiatry 2005 4 16 doi 1744-859X-4-16 This article is available from http content 4 1 16 2005 Husain et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background Depression during pregnancy can have significant health consequences for the mother and her infant. Antidepressant medications which pass through the placenta may increase the risk of low birth weight and preterm delivery. The use of selective serotonin reuptake inhibitors SSRIs during pregnancy may induce serotonergic symptoms in the infant after delivery. Antidepressant medications in breast milk may also be passed to an infant. Vagus nerve stimulation VNS therapy is an effective non-pharmacologic treatment for treatment-resistant depression TRD but little information exists regarding the use of VNS therapy during pregnancy. Case presentation The patient began receiving VNS therapy for TRD in March 1999. The therapy was effective producing substantial reductions in depressive symptoms and improvement of function. In 2002 the patient reported that .